MKC Strategic Solutions
Published Work

Writing that tracks the policy as it moves

Contributor at Pharmacy Times, editorial advisor at Dispense Times — recent articles have drawn 400–600 pageviews against a roughly 300 site average.

Pharmacy Times
What the Peptide Vote Actually Changes at My Counter
On-the-ground read of the FDA PCAC peptide reclassification and its counter-level impact.
2026
Pharmacy Times
Two Weeks In: What the Medicare GLP-1 Bridge Actually Looks Like at the Counter
Early field analysis of the Medicare GLP-1 bridge program's real-world mechanics.
2026
Pharmacy Times
GLP-1s and Oncology Drug Interactions
Clinical interaction risks as GLP-1 use expands across patient populations.
2026
Pharmacy Times
Closing the Prior Authorization Information Gap
Why independent pharmacies absorb the PA burden, and what closes the information gap.
2026
Pharmacy Times
PBM Price Negotiations Have Unintended Consequences for Independent Pharmacies
How independent pharmacies can respond to PBM pricing pressure through advocacy and new revenue strategies.
2026
The Guardian
'It's a Peptide Wild West': How RFK Jr Is Clearing the Way for a Market of Untested Drugs
Featured pharmacist perspective on peptide compounding and patient access.
2026
Dispense Times
Pharmacy Access & Reimbursement Advisor, Editorial Advisory Board
Advisory perspective on GLP-1s, peptides, and specialty access trends.
Ongoing
Start a conversation More about Mohammed